nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxandrolone—Oligospermia—Gemcitabine—kidney cancer	0.0533	0.0549	CcSEcCtD
Oxandrolone—Azoospermia—Gemcitabine—kidney cancer	0.0415	0.0427	CcSEcCtD
Oxandrolone—Menstruation irregular—Everolimus—kidney cancer	0.0301	0.031	CcSEcCtD
Oxandrolone—Hirsutism—Everolimus—kidney cancer	0.0287	0.0295	CcSEcCtD
Oxandrolone—Hirsutism—Erlotinib—kidney cancer	0.0277	0.0285	CcSEcCtD
Oxandrolone—Acne—Temsirolimus—kidney cancer	0.0266	0.0274	CcSEcCtD
Oxandrolone—Oligospermia—Doxorubicin—kidney cancer	0.0236	0.0243	CcSEcCtD
Oxandrolone—Creatinine increased—Temsirolimus—kidney cancer	0.0236	0.0242	CcSEcCtD
Oxandrolone—Creatinine increased—Pazopanib—kidney cancer	0.0222	0.0228	CcSEcCtD
Oxandrolone—Fluid retention—Temsirolimus—kidney cancer	0.0213	0.0219	CcSEcCtD
Oxandrolone—Acne—Everolimus—kidney cancer	0.0198	0.0204	CcSEcCtD
Oxandrolone—Acne—Erlotinib—kidney cancer	0.0191	0.0197	CcSEcCtD
Oxandrolone—Azoospermia—Doxorubicin—kidney cancer	0.0184	0.0189	CcSEcCtD
Oxandrolone—Creatinine increased—Everolimus—kidney cancer	0.0175	0.018	CcSEcCtD
Oxandrolone—Necrosis—Dactinomycin—kidney cancer	0.0168	0.0173	CcSEcCtD
Oxandrolone—Acne—Sunitinib—kidney cancer	0.0166	0.017	CcSEcCtD
Oxandrolone—Hepatic necrosis—Paclitaxel—kidney cancer	0.0161	0.0166	CcSEcCtD
Oxandrolone—Fluid retention—Everolimus—kidney cancer	0.0158	0.0163	CcSEcCtD
Oxandrolone—Blood creatinine increased—Temsirolimus—kidney cancer	0.0152	0.0157	CcSEcCtD
Oxandrolone—Neoplasm—Vinblastine—kidney cancer	0.0151	0.0156	CcSEcCtD
Oxandrolone—Neoplasm—Everolimus—kidney cancer	0.0151	0.0155	CcSEcCtD
Oxandrolone—Creatinine increased—Sunitinib—kidney cancer	0.0146	0.0151	CcSEcCtD
Oxandrolone—Blood creatinine increased—Pazopanib—kidney cancer	0.0144	0.0148	CcSEcCtD
Oxandrolone—Hirsutism—Capecitabine—kidney cancer	0.0132	0.0136	CcSEcCtD
Oxandrolone—Neoplasm—Sorafenib—kidney cancer	0.0131	0.0135	CcSEcCtD
Oxandrolone—Gynaecomastia—Sorafenib—kidney cancer	0.013	0.0133	CcSEcCtD
Oxandrolone—Neoplasm—Sunitinib—kidney cancer	0.0126	0.013	CcSEcCtD
Oxandrolone—Necrosis—Paclitaxel—kidney cancer	0.0119	0.0123	CcSEcCtD
Oxandrolone—Creatinine increased—Gemcitabine—kidney cancer	0.0117	0.0121	CcSEcCtD
Oxandrolone—Irritability—Everolimus—kidney cancer	0.0116	0.0119	CcSEcCtD
Oxandrolone—Blood creatinine increased—Everolimus—kidney cancer	0.0113	0.0117	CcSEcCtD
Oxandrolone—Haemoglobin—Pazopanib—kidney cancer	0.0107	0.011	CcSEcCtD
Oxandrolone—Fluid retention—Gemcitabine—kidney cancer	0.0106	0.0109	CcSEcCtD
Oxandrolone—Haemorrhage—Pazopanib—kidney cancer	0.0106	0.0109	CcSEcCtD
Oxandrolone—Erectile dysfunction—Everolimus—kidney cancer	0.00964	0.00991	CcSEcCtD
Oxandrolone—Blood creatinine increased—Sunitinib—kidney cancer	0.00947	0.00975	CcSEcCtD
Oxandrolone—Fluid retention—Paclitaxel—kidney cancer	0.00888	0.00914	CcSEcCtD
Oxandrolone—Neoplasm—Paclitaxel—kidney cancer	0.00846	0.0087	CcSEcCtD
Oxandrolone—Haemoglobin—Vinblastine—kidney cancer	0.00845	0.00869	CcSEcCtD
Oxandrolone—Haemoglobin—Everolimus—kidney cancer	0.00842	0.00866	CcSEcCtD
Oxandrolone—Haemorrhage—Vinblastine—kidney cancer	0.00841	0.00865	CcSEcCtD
Oxandrolone—Haemorrhage—Everolimus—kidney cancer	0.00838	0.00862	CcSEcCtD
Oxandrolone—Erectile dysfunction—Sorafenib—kidney cancer	0.00837	0.00861	CcSEcCtD
Oxandrolone—Haemoglobin—Erlotinib—kidney cancer	0.00812	0.00836	CcSEcCtD
Oxandrolone—Haemorrhage—Erlotinib—kidney cancer	0.00808	0.00831	CcSEcCtD
Oxandrolone—Oedema—Temsirolimus—kidney cancer	0.008	0.00823	CcSEcCtD
Oxandrolone—Blood creatinine increased—Gemcitabine—kidney cancer	0.0076	0.00782	CcSEcCtD
Oxandrolone—Oedema—Pazopanib—kidney cancer	0.00754	0.00775	CcSEcCtD
Oxandrolone—Haemoglobin—Sorafenib—kidney cancer	0.00731	0.00752	CcSEcCtD
Oxandrolone—Fluid retention—Capecitabine—kidney cancer	0.00729	0.0075	CcSEcCtD
Oxandrolone—Haemorrhage—Sorafenib—kidney cancer	0.00727	0.00748	CcSEcCtD
Oxandrolone—Insomnia—Temsirolimus—kidney cancer	0.00724	0.00744	CcSEcCtD
Oxandrolone—Haemoglobin—Sunitinib—kidney cancer	0.00703	0.00723	CcSEcCtD
Oxandrolone—Haemorrhage—Sunitinib—kidney cancer	0.007	0.0072	CcSEcCtD
Oxandrolone—Neoplasm—Capecitabine—kidney cancer	0.00694	0.00714	CcSEcCtD
Oxandrolone—Insomnia—Pazopanib—kidney cancer	0.00682	0.00701	CcSEcCtD
Oxandrolone—Erectile dysfunction—Vincristine—kidney cancer	0.00681	0.007	CcSEcCtD
Oxandrolone—Blood creatinine increased—Paclitaxel—kidney cancer	0.00636	0.00655	CcSEcCtD
Oxandrolone—Necrosis—Doxorubicin—kidney cancer	0.00631	0.00649	CcSEcCtD
Oxandrolone—Oedema—Everolimus—kidney cancer	0.00595	0.00612	CcSEcCtD
Oxandrolone—Oedema—Erlotinib—kidney cancer	0.00574	0.00591	CcSEcCtD
Oxandrolone—Haemoglobin—Gemcitabine—kidney cancer	0.00564	0.0058	CcSEcCtD
Oxandrolone—Jaundice cholestatic—Doxorubicin—kidney cancer	0.00563	0.0058	CcSEcCtD
Oxandrolone—Haemorrhage—Gemcitabine—kidney cancer	0.00561	0.00577	CcSEcCtD
Oxandrolone—Insomnia—Everolimus—kidney cancer	0.00538	0.00554	CcSEcCtD
Oxandrolone—Irritability—Capecitabine—kidney cancer	0.00532	0.00547	CcSEcCtD
Oxandrolone—Blood creatinine increased—Capecitabine—kidney cancer	0.00522	0.00537	CcSEcCtD
Oxandrolone—Creatinine increased—Doxorubicin—kidney cancer	0.0052	0.00535	CcSEcCtD
Oxandrolone—Insomnia—Erlotinib—kidney cancer	0.00519	0.00534	CcSEcCtD
Oxandrolone—Oedema—Sunitinib—kidney cancer	0.00497	0.00511	CcSEcCtD
Oxandrolone—Haemoglobin—Paclitaxel—kidney cancer	0.00472	0.00486	CcSEcCtD
Oxandrolone—Oedema—Dactinomycin—kidney cancer	0.00471	0.00484	CcSEcCtD
Oxandrolone—Fluid retention—Doxorubicin—kidney cancer	0.0047	0.00483	CcSEcCtD
Oxandrolone—Haemorrhage—Paclitaxel—kidney cancer	0.0047	0.00483	CcSEcCtD
Oxandrolone—Insomnia—Sunitinib—kidney cancer	0.0045	0.00462	CcSEcCtD
Oxandrolone—Neoplasm—Doxorubicin—kidney cancer	0.00448	0.0046	CcSEcCtD
Oxandrolone—Oedema—Vincristine—kidney cancer	0.0042	0.00432	CcSEcCtD
Oxandrolone—Oedema—Gemcitabine—kidney cancer	0.00399	0.0041	CcSEcCtD
Oxandrolone—Haemoglobin—Capecitabine—kidney cancer	0.00388	0.00399	CcSEcCtD
Oxandrolone—Haemorrhage—Capecitabine—kidney cancer	0.00386	0.00397	CcSEcCtD
Oxandrolone—Insomnia—Vincristine—kidney cancer	0.0038	0.00391	CcSEcCtD
Oxandrolone—Insomnia—Gemcitabine—kidney cancer	0.00361	0.00371	CcSEcCtD
Oxandrolone—Blood creatinine increased—Doxorubicin—kidney cancer	0.00337	0.00346	CcSEcCtD
Oxandrolone—Oedema—Paclitaxel—kidney cancer	0.00334	0.00343	CcSEcCtD
Oxandrolone—Insomnia—Paclitaxel—kidney cancer	0.00302	0.00311	CcSEcCtD
Oxandrolone—Oedema—Capecitabine—kidney cancer	0.00274	0.00282	CcSEcCtD
Oxandrolone—Haemoglobin—Doxorubicin—kidney cancer	0.0025	0.00257	CcSEcCtD
Oxandrolone—Haemorrhage—Doxorubicin—kidney cancer	0.00249	0.00256	CcSEcCtD
Oxandrolone—Insomnia—Capecitabine—kidney cancer	0.00248	0.00255	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CITED1—kidney cancer	0.00198	0.0781	CbGpPWpGaD
Oxandrolone—Oedema—Doxorubicin—kidney cancer	0.00177	0.00182	CcSEcCtD
Oxandrolone—Insomnia—Doxorubicin—kidney cancer	0.0016	0.00164	CcSEcCtD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—TFE3—kidney cancer	0.00143	0.0565	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MITF—kidney cancer	0.00074	0.0292	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—EGR1—kidney cancer	0.000691	0.0272	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—FOSL1—kidney cancer	0.000608	0.024	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—HIF1A—kidney cancer	0.000529	0.0209	CbGpPWpGaD
Oxandrolone—Progesterone—CYP1A1—kidney cancer	0.000526	0.205	CrCbGaD
Oxandrolone—Spironolactone—ABCB1—kidney cancer	0.000517	0.202	CrCbGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—RAF1—kidney cancer	0.00051	0.0201	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—KDR—kidney cancer	0.000506	0.02	CbGpPWpGaD
Oxandrolone—Testosterone—CYP1A1—kidney cancer	0.000497	0.194	CrCbGaD
Oxandrolone—Norethindrone—ABCB1—kidney cancer	0.00048	0.187	CrCbGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HSPD1—kidney cancer	0.000458	0.018	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—CDKN2B—kidney cancer	0.000428	0.0169	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000389	0.0154	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000389	0.0154	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—IL13—kidney cancer	0.000384	0.0152	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000369	0.0146	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—MAPK3—kidney cancer	0.000368	0.0145	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—CD4—kidney cancer	0.000357	0.0141	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TSC1—kidney cancer	0.000356	0.014	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—ANXA1—kidney cancer	0.000356	0.014	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—CDKN1B—kidney cancer	0.000353	0.0139	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—MAPK1—kidney cancer	0.00035	0.0138	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—AURKA—kidney cancer	0.000346	0.0137	CbGpPWpGaD
Oxandrolone—AR—FOXA1 transcription factor network—JUN—kidney cancer	0.000336	0.0133	CbGpPWpGaD
Oxandrolone—AR—Notch-mediated HES/HEY network—CDKN1B—kidney cancer	0.000335	0.0132	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	0.000321	0.0127	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PAK1—kidney cancer	0.00032	0.0126	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CDKN2A—kidney cancer	0.000307	0.0121	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—kidney cancer	0.000305	0.012	CbGpPWpGaD
Oxandrolone—AR—Nongenotropic Androgen signaling—PIK3CA—kidney cancer	0.000304	0.012	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	0.000295	0.0116	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—EGR1—kidney cancer	0.000291	0.0115	CbGpPWpGaD
Oxandrolone—AR—Regulation of Androgen receptor activity—JUN—kidney cancer	0.00029	0.0114	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—kidney cancer	0.00028	0.0111	CbGpPWpGaD
Oxandrolone—Progesterone—ABCB1—kidney cancer	0.00028	0.109	CrCbGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	0.000265	0.0104	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	0.000265	0.0104	CbGpPWpGaD
Oxandrolone—Testosterone—ABCB1—kidney cancer	0.000264	0.103	CrCbGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRCA2—kidney cancer	0.000262	0.0104	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CCND1—kidney cancer	0.00026	0.0102	CbGpPWpGaD
Oxandrolone—AR—Coregulation of Androgen receptor activity—CTNNB1—kidney cancer	0.000257	0.0101	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	0.000248	0.00977	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—kidney cancer	0.000247	0.00975	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HARS—kidney cancer	0.000238	0.0094	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—RELA—kidney cancer	0.000219	0.00862	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	0.000217	0.00858	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	0.000216	0.0085	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	0.000211	0.00831	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—kidney cancer	0.000209	0.00824	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—kidney cancer	0.000209	0.00822	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TSC2—kidney cancer	0.000207	0.00818	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—kidney cancer	0.000207	0.00816	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—JUN—kidney cancer	0.000206	0.00814	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EIF5B—kidney cancer	0.000203	0.008	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000203	0.00799	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CCND1—kidney cancer	0.000192	0.00757	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—JUN—kidney cancer	0.000191	0.00755	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—CTNNB1—kidney cancer	0.00019	0.00749	CbGpPWpGaD
Oxandrolone—AR—Androgen receptor signaling pathway—PTEN—kidney cancer	0.000185	0.0073	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—BRAF—kidney cancer	0.000172	0.00679	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CDH1—kidney cancer	0.000169	0.00665	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—kidney cancer	0.000168	0.00661	CbGpPWpGaD
Oxandrolone—AR—Regulation of nuclear SMAD2/3 signaling—MYC—kidney cancer	0.000166	0.00654	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	0.000152	0.00599	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MTOR—kidney cancer	0.00014	0.00554	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—JUNB—kidney cancer	0.000132	0.00519	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EEF2—kidney cancer	0.000131	0.00515	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CCND1—kidney cancer	0.000126	0.00496	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—JUN—kidney cancer	0.000125	0.00495	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—TET2—kidney cancer	0.000125	0.00494	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—CTNNB1—kidney cancer	0.000124	0.00491	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—JUN—kidney cancer	0.000122	0.00482	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—PTEN—kidney cancer	0.000121	0.00478	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	0.000121	0.00478	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	0.000119	0.0047	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	0.000118	0.00465	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	0.000115	0.00455	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—TCEB1—kidney cancer	0.000115	0.00452	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—TCEB2—kidney cancer	0.000115	0.00452	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—VEGFA—kidney cancer	0.00011	0.00432	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	0.000109	0.00431	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000107	0.00422	CbGpPWpGaD
Oxandrolone—AR—SIDS Susceptibility Pathways—VEGFA—kidney cancer	0.000107	0.00421	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	0.000104	0.00411	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	0.000104	0.0041	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	0.000103	0.00407	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MYC—kidney cancer	0.000101	0.00398	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	0.000101	0.00396	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—MAPK1—kidney cancer	9.86e-05	0.00389	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—KRAS—kidney cancer	9.32e-05	0.00367	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—RPL14—kidney cancer	9.31e-05	0.00367	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	9.08e-05	0.00358	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	8.59e-05	0.00339	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	8.35e-05	0.00329	CbGpPWpGaD
Oxandrolone—AR—Integrated Breast Cancer Pathway—TP53—kidney cancer	8.28e-05	0.00327	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	8.17e-05	0.00322	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.72e-05	0.00304	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—HSPB1—kidney cancer	7.59e-05	0.00299	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—EIF4EBP1—kidney cancer	7.59e-05	0.00299	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	7.09e-05	0.0028	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—PSMD7—kidney cancer	7.06e-05	0.00278	CbGpPWpGaD
Oxandrolone—AR—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.86e-05	0.00271	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—JUNB—kidney cancer	6.33e-05	0.0025	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—CDKN2B—kidney cancer	5.16e-05	0.00203	CbGpPWpGaD
Oxandrolone—AR—Generic Transcription Pathway—MYC—kidney cancer	4.15e-05	0.00164	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MAPK3—kidney cancer	2.05e-05	0.00081	CbGpPWpGaD
Oxandrolone—AR—Gene Expression—MYC—kidney cancer	2e-05	0.000788	CbGpPWpGaD
